Your browser doesn't support javascript.
loading
Artificial intelligence predictive analytics in heart failure: results of the pilot phase of a pragmatic randomized clinical trial.
Sideris, Konstantinos; Weir, Charlene R; Schmalfuss, Carsten; Hanson, Heather; Pipke, Matt; Tseng, Po-He; Lewis, Neil; Sallam, Karim; Bozkurt, Biykem; Hanff, Thomas; Schofield, Richard; Larimer, Karen; Kyriakopoulos, Christos P; Taleb, Iosif; Brinker, Lina; Curry, Tempa; Knecht, Cheri; Butler, Jorie M; Stehlik, Josef.
Afiliação
  • Sideris K; Cardiology Section, Medical Service, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, United States.
  • Weir CR; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84112, United States.
  • Schmalfuss C; Cardiology Section, Medical Service, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, United States.
  • Hanson H; Department of Biomedical Informatics, School of Medicine, University of Utah, Salt Lake City, UT 84108, United States.
  • Pipke M; Cardiology Section, Medical Service, Malcom Randall VA Medical Center, Gainesville, FL 32608, United States.
  • Tseng PH; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Florida College of Medicine, Gainesville, FL 32610, United States.
  • Lewis N; Cardiology Section, Medical Service, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, United States.
  • Sallam K; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84112, United States.
  • Bozkurt B; PhysIQ, Inc., Chicago, IL 60563, United States.
  • Hanff T; PhysIQ, Inc., Chicago, IL 60563, United States.
  • Schofield R; Cardiology Section, Medical Service, Hunter Holmes McGuire Veterans Medical Center, Richmond, VA 23249, United States.
  • Larimer K; Department of Internal Medicine, Division of Cardiovascular Disease, Virginia Commonwealth University, Richmond, VA 23249, United States.
  • Kyriakopoulos CP; Cardiology Section, Medical Service, VA Palo Alto Health Care System, Palo Alto, CA 94304, United States.
  • Taleb I; Division of Cardiovascular Medicine, Department of Internal Medicine, Stanford University School of Medicine, Stanford, CA 94305, United States.
  • Brinker L; Cardiology Section, Medical Service, Michael E. DeBakey VA Medical Center, Houston, TX 77030, United States.
  • Curry T; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, United States.
  • Knecht C; Cardiology Section, Medical Service, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT 84148, United States.
  • Butler JM; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84112, United States.
  • Stehlik J; Cardiology Section, Medical Service, Malcom Randall VA Medical Center, Gainesville, FL 32608, United States.
J Am Med Inform Assoc ; 31(4): 919-928, 2024 04 03.
Article em En | MEDLINE | ID: mdl-38341800
ABSTRACT

OBJECTIVES:

We conducted an implementation planning process during the pilot phase of a pragmatic trial, which tests an intervention guided by artificial intelligence (AI) analytics sourced from noninvasive monitoring data in heart failure patients (LINK-HF2). MATERIALS AND

METHODS:

A mixed-method analysis was conducted at 2 pilot sites. Interviews were conducted with 12 of 27 enrolled patients and with 13 participating clinicians. iPARIHS constructs were used for interview construction to identify workflow, communication patterns, and clinician's beliefs. Interviews were transcribed and analyzed using inductive coding protocols to identify key themes. Behavioral response data from the AI-generated notifications were collected.

RESULTS:

Clinicians responded to notifications within 24 hours in 95% of instances, with 26.7% resulting in clinical action. Four implementation themes emerged (1) High anticipatory expectations for reliable patient communications, reduced patient burden, and less proactive provider monitoring. (2) The AI notifications required a differential and tailored balance of trust and action advice related to role. (3) Clinic experience with other home-based programs influenced utilization. (4) Responding to notifications involved significant effort, including electronic health record (EHR) review, patient contact, and consultation with other clinicians.

DISCUSSION:

Clinician's use of AI data is a function of beliefs regarding the trustworthiness and usefulness of the data, the degree of autonomy in professional roles, and the cognitive effort involved.

CONCLUSION:

The implementation planning analysis guided development of strategies that addressed communication technology, patient education, and EHR integration to reduce clinician and patient burden in the subsequent main randomized phase of the trial. Our results provide important insights into the unique implications of implementing AI analytics into clinical workflow.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: J Am Med Inform Assoc Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Revista: J Am Med Inform Assoc Ano de publicação: 2024 Tipo de documento: Article